返回
BioInvent International AB（BOVNF）价格
BOVNF 股价走势图
BOVNF 股息
BioInvent International AB
$0
0%
$0
收盘价：Feb 13, 16:00:00 GMT-5
$0
0%
$0
盘后：Feb 13, 20:00:00 GMT-5
关键数据
前收盘价
--
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
--
每股收益（TTM）
--
股息收益率
--
市值
--
什么是 BIOINVENT INTERNATIONAL AB？
BioInvent International AB is a clinical-stage biotech company that discovers and develops novel and immuno-modulatory antibodies for cancer therapy. The company is headquartered in Lund, Skane and currently employs 124 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.
